Integrated drug development
The Centre for Integrated Preclinical Drug Development (CIPDD) is a unique GLP-accredited biomedical discovery-translation and drug development facility in Australia. Our researchers are working in collaboration with industry and academic partners on research aimed at bringing innovation into new drug development methods to improve preclinical to clinical research translation. We have highly specialized expertise in the methods used for efficacy profiling in the pain field that is unique in Australia and rare internationally. Additionally, we undertake collaborative research with clinicians aimed at generating new insights to inform clinical practice.